Stenting versus medical treatment alone for symptomatic intracranial artery stenosis: a preplanned pooled individual patient data analysis

医学 冲程(发动机) 狭窄 内科学 随机对照试验 血管成形术 经皮 高脂血症 外科 糖尿病 机械工程 工程类 内分泌学
作者
Tao Wang,Jichang Luo,Tianhua Li,Eyad Almallouhi,Peng Gao,Haozhi Gong,Qian Zhang,Jie Wang,Taoyuan Lu,Yifan Yang,Xiaodong Wang,Zixuan Xing,Бо Лю,Colin P. Derdeyn,Liqun Jiao
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:: jnis-022189
标识
DOI:10.1136/jnis-2024-022189
摘要

Background Whether the safety and efficacy of percutaneous transluminal angioplasty and stenting (PTAS) is significantly different from that of medical treatment alone for symptomatic intracranial arterial stenosis (ICAS) is debatable. A study was undertaken to determine the safety and efficacy of both treatments for symptomatic ICAS. Methods This preplanned pooled individual patient data analysis included 400 participants treated with PTAS and 409 treated with medical treatment alone in two large multicenter randomized clinical trials (SAMMPRIS and CASSISS). Patients were treated with PTAS using a self-expanding stent or medical treatment alone. The primary outcome was stroke or death within 30 days, or ischemic stroke in the territory of the qualifying artery more than 30 days after enrollment. Results Individual data were obtained for 809 patients, 451 from SAMMPRIS and 358 from CASSISS. 400 participants were randomly assigned to the PTAS group and 409 to the medical group. The risk of the primary outcome was not significant between the PTAS and medical groups (17.5% vs 13.2%; HR 1.37 (95% CI 0.96 to 1.95), P=0.08). However, the risk of stroke or death within 30 days was higher in the PTAS group (10.5% vs 4.2%; HR 2.62 (95% CI 1.49 to 4.61), P<0.001). Patients of white ethnicity (HR 1.97, 95% CI 1.17 to 3.31) and those with hyperlipidemia (HR 2.04, 95% CI 1.27 to 3.26) or a transient ischemic attack (TIA) (HR 2.19, 95% CI 1.08 to 4.45) were at higher risk for PTAS. Conclusions PTAS poses an increased risk of short-term stroke/death and therefore is not advised as primary treatment for symptomatic ICAS. A balance exists between stroke risks and revascularization benefits. For patients with asymptomatic ICAS of white ethnicity and those with hyperlipidemia or a history of TIA, a thorough assessment is warranted before considering PTAS. Trial registration ClinicalTrials.gov Identifier: NCT00576693 , NCT01763320 .
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
云氲完成签到 ,获得积分10
2秒前
2秒前
自由的白安完成签到,获得积分10
3秒前
辛勤香岚发布了新的文献求助10
4秒前
魔法面包完成签到,获得积分20
5秒前
羊yang完成签到,获得积分20
7秒前
FashionBoy应助科研通管家采纳,获得10
8秒前
酷波er应助科研通管家采纳,获得10
8秒前
Accepted应助科研通管家采纳,获得10
8秒前
CipherSage应助科研通管家采纳,获得10
8秒前
充电宝应助科研通管家采纳,获得10
8秒前
Lucas应助科研通管家采纳,获得10
8秒前
子车茗应助科研通管家采纳,获得10
8秒前
华仔应助科研通管家采纳,获得30
8秒前
天天快乐应助科研通管家采纳,获得10
8秒前
bkagyin应助科研通管家采纳,获得10
8秒前
彭于晏应助科研通管家采纳,获得10
8秒前
李爱国应助科研通管家采纳,获得10
8秒前
彭于晏应助科研通管家采纳,获得10
8秒前
8秒前
9秒前
9秒前
9秒前
9秒前
所所应助羊yang采纳,获得10
13秒前
微不足道发布了新的文献求助10
13秒前
幽默的友灵完成签到,获得积分10
15秒前
16秒前
红箭烟雨完成签到,获得积分10
16秒前
科研通AI2S应助梅残风暖采纳,获得10
16秒前
cugwzr发布了新的文献求助10
18秒前
爆米花应助微不足道采纳,获得10
21秒前
黄筱妍发布了新的文献求助10
23秒前
长情伊关注了科研通微信公众号
24秒前
加菲丰丰应助奥特曼采纳,获得20
24秒前
26秒前
Asuka完成签到,获得积分10
27秒前
Ppp完成签到 ,获得积分10
27秒前
Lucas应助意意采纳,获得10
29秒前
31秒前
高分求助中
The Oxford Handbook of Social Cognition (Second Edition, 2024) 1050
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
COSMETIC DERMATOLOGY & SKINCARE PRACTICE 388
Case Research: The Case Writing Process 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3141451
求助须知:如何正确求助?哪些是违规求助? 2792469
关于积分的说明 7803043
捐赠科研通 2448691
什么是DOI,文献DOI怎么找? 1302778
科研通“疑难数据库(出版商)”最低求助积分说明 626650
版权声明 601237